Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Innovation in Antineoplastic Drug Infusion: A Multiphase Observational Study of Air-in-Line Alarms, Safety, and Therapeutic Continuity

NCT07718711 is registered in ClinicalTrials.gov with Associazione Italiana Infermieri di Area Oncologica as lead sponsor.

NCT NCT07718711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07718711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Innovation in Antineoplastic Drug Infusion: A Multiphase Observational Study of Air-in-Line Alarms, Safety, and Therapeutic Continuity
Lead sponsor
Associazione Italiana Infermieri di Area Oncologica
Phase
Observational
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
June 1, 2028
Enrollment
40 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

air-in-line alarm, antineoplastic drug administration, infusion safety, medication safety